Alder Matthias 4
4 · Gain Therapeutics, Inc. · Filed Sep 22, 2023
Insider Transaction Report
Form 4
Alder Matthias
CHIEF OPERATING OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-09-20−2,550→ 7,650 total→ Common Stock (2,550 underlying) - Exercise/Conversion
Common Stock
2023-09-20+2,550→ 5,850 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.